Medtronic has maintained its status as one of the most inventive companies in Australia and New Zealand after receiving more recognition as a health technology leader.
Its robotic solution for a patient remote monitoring service ranked it second in the health industry category of the 2020 Most Innovative Companies list.
Medtronic was among more than 600 companies nominated for the prestigious annual report, published by the Australian Financial Review and Boss Magazine.
Last year it was third in the same category for an insulin pump system.
“I’m proud to see Medtronic rise to the top of the innovative health industry once again,” said Liz Carnabuci, vice-president and managing director of the global firm’s Australasia operations.
“It’s a true testament to the dedication of our employees in delivering state-of-the-art technology and innovation.”
Medtronic’s CareLink 360 device has improved patient survival rates, allowing round-the-clock remote surveillance of people with implantable pacemakers, defibrillators and cardiac monitors.
Previously, clinicians had to manually filter and manage large amounts of data – but the robotic solution automatically transfers that output into reports and extracts the clinically-relevant text and images to create a meaningful summary for the patients’ healthcare provider.
The service can now support more than 26,000 patients, improving the workflow for 315 cardiologists and cardiac electrophysiologists.
“At Medtronic, we continuously work with clinicians to identify ways to better support them and their patients,” Ms Carnabuci said.
“Once we learned that previous manual processes had been exhausted, robotic process automation was identified as the solution to take our efficiency and quality of care to a new level, which had been previously unobtainable.”
The list, now in its ninth year, is based on a rigorous assessment process managed by Australia’s leading innovation consultancy, Inventium, along with a panel of industry expert judges.
Medtronic is an APHA Major Sponsor.
